Company - Corporate Actions - Earnings
Glaxosmithkline plc (GSK) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The estimated EPS is $0.76
...
January 31, 2024 GSK 1.06%
Teva- Pharmaceutical Industries Ltd. (TEVA) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 29, 2023.The estimated EPS is $0.75
...
January 31, 2024 TEVA -1.26%
Fangdd Network Group Ltd (DUO) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 31, 2023.The estimated revenue is $26154000
...
January 31, 2024 DUO -3.86%
Novo Nordisk (NVO) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The estimated EPS is $0.66
...
January 31, 2024 NVO 1.46%
Redhill Biopharma (RDHL) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The annoucened EPS was $-22.4The estimated revenue is $17552000
...
January 31, 2024 RDHL -0.53%
Banco Santander S.A. (SAN) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The estimated EPS is $0.18
...
January 31, 2024 SAN 0.89%
Nomura Holdings Inc. (NMR) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.
...
January 31, 2024 NMR 1.44%
Novartis AG (NVS) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The estimated EPS is $1.67
...
January 31, 2024 NVS 0.77%
AIU (AIU) confirmed earnings release on January 31, 2024, Before the market for the quarter ending November 29, 2023.
...
January 31, 2024 NVS 0.77%
Banco Santander (Brasil) S.A. (BSBR) confirmed earnings release on January 31, 2024, Before the market for the quarter ending December 30, 2023.The estimated EPS is $0.15
...
January 31, 2024 BSBR 0.92%